NineSigma, representing Suntory Global Innovation Center Ltd. (“Client”), which serves as the Suntory Group's basic research department, seeks technologies for making a minimally invasive assessment of cellular senescence in the human clinical setting. The Client has in mind biomarker-based assessment methods but welcomes proposals for a wide range of other approaches.
Image credit: BruceBlaus/Wikipedia/CC BY-SA 4.0
Anti-ageing is one of the major targets in the research on functional food. By establishing technology for assessing cellular senescence based on a minimally invasive sampling technique, the Client aspires to advance the anti-ageing research in humans with a focus on food.
Possible approaches may include, but are not limited to:
- Technology for biomarker-based assessment of cellular senescence
- Fluorometric quantification based on staining for SA-βGal, γH2AX, etc.
- Quantitative assessment of cellular senescence using image-processing technology
Submissions to this Challenge must be received by Feb 8, 2021.
Source: NineSights